作者更正:丝氨酸蛋白酶抑制剂A3是可溶性SIRPα配体,可抑制炎症和抗肿瘤免疫
Author Correction: Serine protease inhibitor A3 is a soluble SIRPα ligand that suppresses inflammation and antitumor immunity
该声明是对《自然免疫学》在线发表文章《丝氨酸蛋白酶抑制剂A3是可溶性SIRPα配体,可抑制炎症和抗肿瘤免疫》的图片更正。因图片文件准备错误及生产失误,原稿图1–7中存在错误的印迹图像、缺失的轴标签、缺失的数据连线以及异常箭头等问题,现已在HTML和PDF版本中修正,并提供补充信息供对比。
- Author Correction
- Published: 12 November 2026
- Yufei Hou1,2,3 na1,
- Lei Huang1,2 na1,
- Chunhui Jin1,2,4,
- Xiaolong Li1,2,
- Yongxing Chen ORCID: orcid.org/0009-0005-0056-11361,2,
- Liguang Sun1,2,
- Feng Wang ORCID: orcid.org/0009-0004-7162-255X1,2,
- Yong Zhang1,5,
- Ying Wang1,2,6,
- Meijuan Zou1,2,6,
- Qina Xu6,
- Zicheng Wang6,
- Tao Jin6,
- Naicui Zhai1,2,
- Fei Xu1,2,
- Wentao Liu ORCID: orcid.org/0000-0001-5534-71731,2 &
- …
- Yong-Guang Yang ORCID: orcid.org/0000-0003-4985-12471,2,3
Nature Immunology (2026) Cite this article
Correction to: Nature Immunology https://doi.org/10.1038/s41590-026-02682-5, published online 22 October 2026.
In the version of this article initially published, due to figure file-preparation mistakes, there were errors in Figs. 1–6. In Fig. 1i, incorrect blot images were presented; in Fig. 2j, an x-axis label and arrow were missing; in Fig. 3d, e, incorrect flow cytometry plots were shown, while a bar plot in Fig. 3e and a header label in Fig. 3f were omitted; in Figs. 4d, 5e and 6j, incorrect blots were presented. Separately, due to production errors, in Fig. 3n, trace lines were missing between data points; in Fig. 6d, an artifactual arrow was present over a plot; in Fig. 6l, data points in the last column of the bar chart appeared over the second-to-last column; in Fig. 7j, k, header labels were missing. The figures are now amended in the HTML and PDF versions of the article. For comparison, the original figures are available as Supplementary Information accompanying this amendment.
Author information
Author notes
These authors contributed equally: Yufei Hou, Lei Huang.
Authors and Affiliations
Key Laboratory of Organ Regeneration & Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun, China
Yufei Hou, Lei Huang, Chunhui Jin, Xiaolong Li, Yongxing Chen, Liguang Sun, Feng Wang, Yong Zhang, Ying Wang, Meijuan Zou, Naicui Zhai, Fei Xu, Wentao Liu & Yong-Guang Yang
National-local Joint Engineering Laboratory of Animal Models for Human Diseases, Jilin University, Changchun, China
Yufei Hou, Lei Huang, Chunhui Jin, Xiaolong Li, Yongxing Chen, Liguang Sun, Feng Wang, Ying Wang, Meijuan Zou, Naicui Zhai, Fei Xu, Wentao Liu & Yong-Guang Yang
International Center of Future Science, Jilin University, Changchun, China
Yufei Hou & Yong-Guang Yang
Department of Pathology, The First Hospital of Jilin University, Changchun, China
Chunhui Jin
Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, China
Yong Zhang
Department of Neurology, Neuroscience Center, The First Hospital of Jilin University, Changchun, China
Ying Wang, Meijuan Zou, Qina Xu, Zicheng Wang & Tao Jin
Authors
- Yufei Hou
- Lei Huang
- Chunhui Jin
- Xiaolong Li
- Yongxing Chen
- Liguang Sun
- Feng Wang
- Yong Zhang
- Ying Wang
- Meijuan Zou
- Qina Xu
- Zicheng Wang
- Tao Jin
- Naicui Zhai
- Fei Xu
- Wentao Liu
- Yong-Guang Yang
Corresponding authors
Correspondence to Wentao Liu or Yong-Guang Yang.
About this article
Cite this article
Hou, Y., Huang, L., Jin, C. et al. Author Correction: Serine protease inhibitor A3 is a soluble SIRPα ligand that suppresses inflammation and antitumor immunity. Nat Immunol (2026). https://doi.org/10.1038/s41590-026-02732-y
Published: 12 November 2026
Version of record: 12 November 2026
DOI: https://doi.org/10.1038/s41590-026-02732-y
来源:Nature Immunology · nature.com